Trastuzumab deruxtecan for treating HER2-positive advanced gastric or gastro-oesophageal junction adenocarcinoma after trastuzumab-based treatment (review of TA879) [ID6680]
In development
Reference number: GID-TA11963
Expected publication date: TBC
Documents
Documents created during the development process.
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators